Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

The home insurance provider boosted its overall funding to $109m in a round co-led by Lennar and backed by Comcast and Munich Re.

Strategic partner Eli Lilly invested $15m while Pfizer, Ping An Ventures and Taiho Ventures also contributed to the immunotherapy developer's series B round.

Pfizer Ventures and 6 Dimensions Capital joined Merck & Co, Sanofi, Eli Lilly and Amgen in Kymera's series B round, taking the protein degradation drug developer's total funding to more than $95m.

LG, Sony, Munich Re, BNP Paribas and Denso have helped the mobility software developer reach a second close following a $28m first tranche in June.

Memory technology supplier and New York University spinout Spin Memory has secured $52m in a round featuring Applied Ventures and Arm.

Memory technology supplier and New York University spinout Spin Memory has secured $52m in a round featuring Applied Ventures and Arm.

Lilly Asia Ventures and existing investor Taiho Ventures both contributed to a round for immunotherapy developer Harpoon Therapeutics following a $45m series B last year.

Siemens' Next47 subsidiary has participated in a series B round led by Mubadala Ventures that boosted the collaborative shipping platform's overall funding to near $100m.